Zdrowie i gospodarka · 18/12/2017

FDA Releases Draft Guidance on Replacement Reagent and Instrument Family Policy for In Vitro Diagnostic Devices

The Food and Drug Administration (FDA) has made available a draft guidance document aimed at updating and clarifying the policy for manufacturers to apply assays to new instruments, replacing a 2003 policy.